Reframing personalised treatment decisions in advanced ovarian cancer in 2023
Please join the expert faculty for an exciting discussion on key advances in the treatment of ovarian cancer in 2023, featuring key perspectives and practical insights.
Dr. Dearbhaile Collins
Cork University Hospital, Ireland
What's changed in the PARPi treatment landscape in 2022?
Professor Charlie Gourley
Edinburgh University Hospital, United Kingdom
The art of personalising first-line maintenance treatment selection
Professor Jonathan Ledermann
University College London Cancer Institute
What is the clinical relevance of recent overall survival data readouts in recurrent ovarian cancer?
20:05 - 20:30
Panel & Audience Discussion
Register to attend this event
NX-IE-NRP-WCNT-230001 April 2023